Dr. Mitrani-Rosenbaum received her PhD in Microbiology from the Hebrew University of Jerusalem. She conducted her postdoctoral studies at the National Institutes of Health and joined the Department of Virology at the Faculty of Medicine of the Hebrew University of Jerusalem, where she conducted research on DNA tumor viruses. After a sabbatical year at the Genetics Department at Harvard University, she joined the Goldyne Savad Institute of Gene Therapy at Hadassah-The Hebrew University Medical Center as a full professor and focused her interest in genetics and muscle diseases.
Since discovering the GNE gene as the underlying cause of GNE myopathy 20 years ago, Dr. Mitrani-Rosenbaum has dedicated her career to advancing the diagnosis, scientific research, and therapeutic discovery in the field. Her contributions, which have been, in part, funded by NDF, include the creation of GNEM cell and animal models, functional analysis ofGNE, establishment of gene therapy vectors, and understanding of disease etiology. Dr. Mitrani-Rosenbaum served as a charter member of NDF’s Scientific Advisory Committee and, in addition to her significant scientific contributions, Dr. Mitrani-Rosenbaum has dedicated herself to training the next generation of scientists who can now follow in her footsteps and continue seeking answers for GNEM. As an ambassador for GNEM, she has played an active role in community education as well as advocating for the lives of patients with GNE Myopathy all over the world
